Fernanda P. Pons‐Faudoa

Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant

Fernanda P. Pons‐Faudoa, Nicola Di Trani, Antons Sizovs et al. · Pharmaceutics · 2020 · 105 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +17

2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis

Fernanda P. Pons‐Faudoa, Antons Sizovs, Nicola Di Trani et al. · Journal of Controlled Release · 2019 · 56 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats

Jesus Paez‐Mayorga, Jocelyn Nikita Campa‐Carranza, Simone Capuani et al. · Nature Communications · 2022 · 53 citations · Full text

Engineering, Bioengineering, Endocrinology +17

Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates

Fernanda P. Pons‐Faudoa, Antons Sizovs, Kathryn A. Shelton et al. · Advanced Therapeutics · 2020 · 41 citations · Full text

Pharmacy, Infectious Diseases, Preventive Medicine +17

Nanofluidic microsystem for sustained intraocular delivery of therapeutics

Nicola Di Trani, Priya Jain, Corrine Ying Xuan Chua et al. · Nanomedicine Nanotechnology Biology and Medicine · 2018 · 34 citations

Pharmacy, Biomedical Engineering, Pharmaceutics +14